92 related articles for article (PubMed ID: 16989169)
1. [Clinical significance of PCNA expression in non-small cell lung cancer].
Dworakowska D
Pneumonol Alergol Pol; 2005; 73(3):292-6. PubMed ID: 16989169
[No Abstract] [Full Text] [Related]
2. Prognostic impact of nm23-H1 and PCNA expression in pathologic stage I non-small cell lung cancer.
Liu C; Liu J; Wang X; Mao W; Jiang L; Ni H; Mo M; Wang W
J Surg Oncol; 2011 Aug; 104(2):181-6. PubMed ID: 21495034
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
[TBL] [Abstract][Full Text] [Related]
4. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
5. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
[TBL] [Abstract][Full Text] [Related]
6. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.
Ebina M; Steinberg SM; Mulshine JL; Linnoila RI
Cancer Res; 1994 May; 54(9):2496-503. PubMed ID: 7909277
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of cyclin E overexpression in resected non-small cell lung cancer.
Fukuse T; Hirata T; Naiki H; Hitomi S; Wada H
Cancer Res; 2000 Jan; 60(2):242-4. PubMed ID: 10667567
[TBL] [Abstract][Full Text] [Related]
8. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data.
Fontanini G; Pingitore R; Bigini D; Vignati S; Pepe S; Ruggiero A; Macchiarini P
Am J Pathol; 1992 Dec; 141(6):1285-90. PubMed ID: 1361306
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen level in serum and pleural lavage fluid in non-small cell lung cancer.
Tomita M; Shimizu T; Ayabe T; Yonei A; Onitsuka T
Thorac Cardiovasc Surg; 2010 Sep; 58(6):350-3. PubMed ID: 20824588
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of tumor interstitial T lymphocyte subset activity in non-small-cell lung cancer].
Xue L; Chen J; Peng JZ; Chen BS; Hua P; Yang YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2456-8. PubMed ID: 20034901
[TBL] [Abstract][Full Text] [Related]
11. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
Volm M; Koomägi R
Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of prostate stem cell antigen expression in non-small cell lung cancer.
Kawaguchi T; Sho M; Tojo T; Yamato I; Nomi T; Hotta K; Hamada K; Suzaki Y; Sugiura S; Kushibe K; Nakajima Y; Taniguchi S
Jpn J Clin Oncol; 2010 Apr; 40(4):319-26. PubMed ID: 20085909
[TBL] [Abstract][Full Text] [Related]
13. Refining prognosis in non-small-cell lung cancer.
Singh T; Dhindsa J
N Engl J Med; 2007 Jan; 356(2):190; author reply 190-1. PubMed ID: 17225287
[No Abstract] [Full Text] [Related]
14. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer.
Macchiarini P; Fontanini G; Hardin MJ; Chuanchieh H; Bigini D; Vignati S; Pingitore R; Angeletti CA
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):80-9. PubMed ID: 8391612
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of preoperative carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: can preoperative carcinoembryonic antigen level predict pathological stage?
Kawachi R; Nakazato Y; Takei H; Koshi-ishi Y; Goya T
Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):199-202. PubMed ID: 19457896
[TBL] [Abstract][Full Text] [Related]
16. Expression of p21 in non small cell lung cancer relationship with PCNA.
Groeger AM; Caputi M; Esposito V; Baldi A; Rossiello R; Santini D; Mancini A; Kaiser HE; Baldi F
Anticancer Res; 2000; 20(5A):3301-5. PubMed ID: 11062757
[TBL] [Abstract][Full Text] [Related]
17. [Has survival of non-small-cell lung cancer patients been ameliorated over the course of the past 20 years?].
Milleron B
Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S31-5. PubMed ID: 16273008
[No Abstract] [Full Text] [Related]
18. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
Morita K; Hayashi Y; Nagao S; Watanabe Y
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():164-7. PubMed ID: 7611782
[TBL] [Abstract][Full Text] [Related]
19. New TNM classification for non-small-cell lung cancer.
Tanoue LT; Detterbeck FC
Expert Rev Anticancer Ther; 2009 Apr; 9(4):413-23. PubMed ID: 19374596
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
